Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 33, 2020 - Issue 3
76
Views
2
CrossRef citations to date
0
Altmetric
Case Studies

The antisynthetase syndrome

, MD & , MD
Pages 401-403 | Received 27 Mar 2020, Accepted 30 Apr 2020, Published online: 18 May 2020

  • Gallay L, Gayed C, Hervier B. Antisynthetase syndrome pathogenesis: knowledge and uncertainties. Curr Opin Rheumatol. 2018;30(6):664–673. doi:10.1097/BOR.0000000000000555.
  • Witt LJ, Curran JJ, Strek ME. The diagnosis and treatment of antisynthetase syndrome. Clin Pulm Med. 2016;23(5):218–226. doi:10.1097/CPM.0000000000000171.
  • Maturu VN, Lakshman A, Bal A, et al. Antisynthetase syndrome: an under-recognized cause of interstitial lung disease. Lung India. 2016;33(1):20–26. doi:10.4103/0970-2113.173055.
  • Marguerie C, Bunn CC, Beynon HLC, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med. 1990;77(1):1019–1038. doi:10.1093/qjmed/77.1.1019.
  • Rüegg CA, Maurer B, Laube I, Scholtze D. Jo1-antisynthetase syndrome and severe interstitial lung disease with organising pneumonia on histopathology with favourable outcome on early combined treatment with corticosteroids, mycophenolate mofetil and rituximab. BMJ Case Rep. 2019;12(9):e231006. doi:10.1136/bcr-2019-231006.
  • Lega J-C, Fabien N, Reynaud Q, et al. The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome. Autoimmun Rev. 2014;13(9):883–891. doi:10.1016/j.autrev.2014.03.004.
  • Richardson C, Haque UJ. Pulmonary capillaritis in a patient with antisynthetase syndrome and anti-PL-7 antibodies. J Clin Rheumatol. 2019;25(6):e91–e92. doi:10.1097/RHU.0000000000000746.
  • Vargas-Gutiérrez DA, Solís-Jiménez F, Arias Callejas KI, et al. Diffuse alveolar hemorrhage in a patient with antisynthetase syndrome. Case Rep Rheumatol. 2019;2019:1–4. doi:10.1155/2019/5453717.
  • Priyangika S, Karunarathna W, Liyanage I, et al. Organizing pneumonia as the first manifestation of anti-synthetase syndrome. BMC Res Notes. 2016;9(1):290. doi:10.1186/s13104-016-2094-3.
  • Svensson J, Holmqvist M, Lundberg IE, Arkema EV. Infections and respiratory tract disease as risk factors for idiopathic inflammatory myopathies: a population-based case-control study. Ann Rheum Dis. 2017;76(11):1803–1808. doi:10.1136/annrheumdis-2017-211174.
  • Casciola-Rosen L, Andrade F, Ulanet D, Wong WB, Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med. 1999;190(6):815–826. doi:10.1084/jem.190.6.815.
  • Connors GR, Christopher-Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest. 2010;138(6):1464–1474. doi:10.1378/chest.10-0180.
  • Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011;37(1):100–109. doi:10.1590/S1806-37132011000100015.
  • Stone KB, Oddis CV, Fertig N, et al. Anti-Jo-1 antibody levels correlate with disease activity in idiopathic inflammatory myopathy. Arthritis Rheum. 2007;56(9):3125–3131. doi:10.1002/art.22865.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.